incretin semaglutide Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition A Tale of Two Incretins

Firstly, it slows down the emptying of the stomach, leading to increased feelings of fullness and reduced appetite

Patients with Type 2 diabetes have many other drug treatment options, including other GLP-1 receptor agonists like Mounjaro (tirzepatide) and Trulicity (dulaglitude)

People who use GLP-1RAs and have GI AEs typically lose a little bit more weight than those who do not

8 Case reports of accidental overdoses, as well as guidance to emergency room clinicians, have also begun to appear in the clinical and pharmacy literature

With that in mind, you likely wont notice any effects of semaglutide therapy during the 8 week titration period